(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMONDYS 45 (CASIMERSEN)

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

AMONDYS 45 (CASIMERSEN)

ST13

US500000090458549

Class

44

Filing

90458549

Registration

7043671

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

05/02/2023

Trademark type

Combined

Nice classes

44

Filing date

01/11/2021

Registration date

05/02/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/02/2023

Last transaction

05/02/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/25/2021

First use in commerce

02/25/2021

Drawing code

3

Owner type

03

Owner location

Cambridge, MA, US

Examiner

CLARKE, NANCY

Law office

L20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a hexagon, bisected by a swoosh, followed by the text and numeral "AMONDYS 45" over the text "(casimersen)".

Holders and representatives

Holders

Sarepta Therapeutics, Inc.

Representatives

Maury M. Tepper, III TEPPER & EYSTER, PLLC

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Providing health information

Publications

History of USPTO decisions and trademark events.

35 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/02/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

05/02/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/29/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/28/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/20/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/20/2023

IUAF

USE AMENDMENT FILED

03/02/2023

EISU

TEAS STATEMENT OF USE RECEIVED

03/02/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/17/2022

EX2G

SOU EXTENSION 2 GRANTED

09/15/2022

EXT2

SOU EXTENSION 2 FILED

09/15/2022

EEXT

SOU TEAS EXTENSION RECEIVED

09/15/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/19/2022

EX1G

SOU EXTENSION 1 GRANTED

02/17/2022

EXT1

SOU EXTENSION 1 FILED

02/17/2022

EEXT

SOU TEAS EXTENSION RECEIVED

02/17/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/21/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/27/2021

PUBO

PUBLISHED FOR OPPOSITION

07/27/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/07/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/24/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

06/24/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/24/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

06/24/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/24/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/23/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/22/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/22/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/05/2021

GNRT

NON-FINAL ACTION E-MAILED

06/05/2021

CNRT

NON-FINAL ACTION WRITTEN

06/05/2021

DOCK

ASSIGNED TO EXAMINER

05/29/2021

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

04/13/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/10/2021

NWAP

NEW APPLICATION ENTERED

01/14/2021

Continuous trademark protection

Get notified about every new filing that threatens AMONDYS 45 (CASIMERSEN) or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.